Limitations of Sulforhodamine 101 for Brain Imaging

2017 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Limitations of Sulforhodamine 101 for Brain Imaging​
Hagos, L.; Heuer, H.; Schnell, C. & Hülsmann, S. ​ (2017) 
Frontiers in Cellular Neuroscience11 art. 44​.​ DOI: https://doi.org/10.3389/fncel.2017.00044 

Documents & Media

fncel-11-00044-g0001.tif3.14 MBUnknownfncel-11-00044-g0002.tif978.16 kBUnknownfncel-11-00044-g0003.tif2.16 MBUnknownfncel-11-00044.pdf2.31 MBUnknown

License

Published Version

Attribution 4.0 CC BY 4.0

Details

Authors
Hagos, Liya; Heuer, Heike; Schnell, Christian; Hülsmann, Swen 
Abstract
Since 2004, the red fluorescent dye Sulforhodamine 101 (SR101) has been boosting the functional analysis of astrocytes in a functional environment in an unprecedented way. However, two major limitations have been challenging the usefulness of this tool for cellular imaging: (i) SR101 is not as specific for astrocytes as previously reported; and (ii) discoveries of severe excitatory side effects of SR101 are bearing the risk of unwanted alteration of the system of interest. In this article, we summarize the current knowledge about SR101-labeling protocols and discuss the problems that arise from varying of the staining protocols. Furthermore, we provide a testable hypothesis for the observed hyper-excitability that can be observed when using SR101.
Issue Date
2017
Status
published
Publisher
Frontiers Media S.A.
Journal
Frontiers in Cellular Neuroscience 
ISSN
1662-5102
eISSN
1662-5102
Language
English
Sponsor
Open-Access-Publiokationsfonds 2017

Reference

Citations


Social Media